What happened
Macrogen updated a previously disclosed supply contract with Korea Research Institute of Bioscience and Biotechnology, now worth US$11.6M, about 13.22% of its recent annual revenue, running through Dec 2026.
For context, this single contract equals about 13.22% of the company's most recent annual revenue.
| Counterparty | Korea Research Institute of Bioscience and Biotechnology |
|---|---|
| Contract value | US$11.6M |
| vs. recent revenue | 13.22% |
| Through | Dec 2026 (from Dec 2024) |
| Filed | 2026-03-27, [Amended] Supply contract signed |
| Source | DART rcept 20260327901596 → open original filing |
Source: DART. Information only, not investment advice.